Clinical management of chronic Chagas cardiomyopathy

Manoel O C Rocha1, Antonio Luiz P Ribeiro, Mauro M Teixeira

  • 1Departamento de Clinica Medica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Avenida Alfredo Balena, 190, Belo Horizonte, MG, Brazil.

Insights

Chagas disease, caused by Trypanosoma cruzi, affects millions globally. This review focuses on diagnosing and managing chagasic cardiopathy, emphasizing parasite persistence in pathogenesis.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Parasitology

Background:

  • Chagas disease, caused by the protozoan Trypanosoma cruzi, impacts over 15 million people worldwide.
  • While new infections are declining due to control programs, a significant population harbors chronic infection, at risk for developing chagasic cardiopathy.
  • Chagasic cardiopathy is a major cause of heart failure and arrhythmias in endemic regions.

Purpose of the Study:

  • To discuss the clinical diagnosis and management of Chagas cardiopathy.
  • To emphasize clinical staging and diagnostic tools for personalized treatment.
  • To highlight the role of parasite persistence in disease pathogenesis.

Main Methods:

  • Review of clinical diagnosis and management strategies for Chagas cardiopathy.
  • Emphasis on clinical staging and utilization of diagnostic tests.
  • Discussion on the relevance of specific antiparasitic treatment.

Main Results:

  • Chagasic cardiopathy presents with heart failure and arrhythmias.
  • Individualized treatment approaches are crucial for managing these syndromes.
  • Parasite persistence is a key factor in the development of Chagasic cardiopathy.

Conclusions:

  • Effective management of Chagas cardiopathy requires accurate diagnosis and staging.
  • Personalized treatment strategies are essential for addressing heart failure and arrhythmias.
  • Understanding the role of parasite persistence is vital for Chagas disease pathogenesis and treatment.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...